Primary Thrombotic Microangiopathy in Pediatric Patients
Background . Primary thrombotic microangiopathy includes hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli , atypical hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Methodology . A retrospective study that included patients younger than 18 years diagnose...
Saved in:
| Main Authors: | Andrés David Aranzazu Ceballos MD, Lina María Martínez Sánchez MSc, Ana Paulina Pamplona Sierra MD, Daniela Vergara Yánez MD, Liliana Franco Hincapié PhD, Richard Baquero Rodriguez MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Global Pediatric Health |
| Online Access: | https://doi.org/10.1177/2333794X241307535 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombotic Microangiopathy: A Devastating Complication After Lung Transplantation
by: Wouter Rosseels, MD, et al.
Published: (2025-04-01) -
Tacrolimus-Induced Thrombotic Microangiopathy in Orthotopic Heart Transplant Patients
by: Faysal Massad, MD, et al.
Published: (2025-07-01) -
Thrombotic Microangiopathy After Lung Transplantation: A Retrospective Observational Multicenter Cohort Study
by: Pierre Gazengel, MD, et al.
Published: (2025-08-01) -
COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01) -
THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01)